AGE-RELATED MACULAR DEGENERATION

This study tested whether a pre-filled syringe of the drug SB11 (a biosimilar to ranibizumab) is easy for doctors to use when treating certain eye diseases. Thirty adults with wet age-related macular degeneration, macular edema from retinal vein occlusion, or myopic choroidal neo…

This study tested a robotic arm that holds a tiny needle steady while a surgeon injects medicine under the retina to treat bleeding caused by age-related macular degeneration. 20 patients having standard surgery took part. The robot helped the surgeon keep the needle in the right…

This study tested a drug normally used for Parkinson's disease (carbidopa-levodopa) in 35 people with wet age-related macular degeneration (AMD). The goal was to see if it could improve vision and reduce the need for standard eye injections. Participants took the oral drug alongs…

This study tested whether the antibiotic minocycline, taken as a pill twice daily for at least 3 years, could safely slow the growth of geographic atrophy (an advanced form of age-related macular degeneration) and help preserve vision. Thirty-seven adults aged 55 and older with g…

This study followed people aged 55 and older with early age-related macular degeneration (AMD) or healthy eyes for up to 5 years. Researchers used eye exams, imaging, and vision tests to track how the disease progresses. The goal was to better understand AMD and find markers that…

This study looked at proteins in the eye fluid of 100 people with age-related macular degeneration (AMD) to understand why some don't respond well to standard anti-VEGF injections. Researchers measured levels of growth-promoting proteins and inflammation markers at the start and …

This study examined 60 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes gradual vision loss. Researchers looked at past medical records and eye images to see how changes in the retina relate to worsening eyesight. No treatments …

This study followed 20 adults aged 55 and older with geographic atrophy, an advanced form of age-related macular degeneration that causes central vision loss. Researchers measured changes in the damaged area of the eye every few months for nearly 4 years. The goal was to learn ho…

This study looked at whether telling healthy adults their genetic risk for age-related macular degeneration (AMD) would encourage them to eat more carotenoid-rich foods, which are good for eye health. Researchers measured skin and eye carotenoid levels in 80 Caucasian participant…

This study looked at whether personalized risk profiles (including genetic testing) and coaching can motivate people with age-related macular degeneration (AMD) to make healthier lifestyle changes. 150 participants with early or intermediate AMD were involved. The goal was to see…